Fig. 5.
The sigmoid EMAX function that describes the influence of ketamine plasma concentration on the efficacy of ketamine inhalation. Plus symbol (+) indicates the concentration causing a 50% reduction in efficacy (B50). The blue arrow indicates the dose-independent loss of drug; the red line, the dose-dependent bioavailability. The thick part of the red line indicates the average ketamine concentration range observed in the study.